Radioiodine Therapy for Thyroid Cancer and Hyperthyroidism in Patients with End-Stage Renal Disease on Hemodialysis
- 1 December 2005
- journal article
- case report
- Published by SAGE Publications in Thyroid®
- Vol. 15 (12) , 1321-1331
Abstract
Treatment with radioactive iodine ((131)I) may be necessary for thyroid cancer or for hyperthyroidism in patients with end-stage renal disease who require hemodialysis. Because (131)I is cleared mainly by the kidneys in patients with normal renal function, many issues arise in patients who require (131)I treatment but who are on hemodialysis. This paper presents a case report of a patient on dialysis who required treatment with (131)I for thyroid cancer. We describe a mathematical model, which suggests that the treatment dose of (131)I for a patient with thyroid cancer on hemodialysis would be approximately 13%-28% of a typical empiric dose of (131)I for a patient with normal renal function. Also, we present a comprehensive review and discussion of the literature on patients who are receiving hemodialysis who were treated with (131)I for either thyroid cancer or hyperthyroidism. Using a multidisciplinary approach and special precautions, (131)I therapy can be administered safely and effectively for patients with thyroid cancer or hyperthyroidism who are receiving hemodialysis.Keywords
This publication has 20 references indexed in Scilit:
- Radioactive 131I Use in End‐Stage Renal Disease: Nightmare or Nuisance?Seminars in Dialysis, 2004
- Disposition of Radioiodine 131I Therapy for Thyroid Carcinoma in a Patient with Severely Impaired Renal Function on Chronic Dialysis: a Case ReportJapanese Journal of Clinical Oncology, 2002
- Radiation protection issues of treating hyperthyroidism with 131I in patients on haemodialysisNuclear Medicine Communications, 2002
- Iodine-131 Treatment of Thyroid Papillary Carcinoma in Patients Undergoing Dialysis for Chronic Renal Failure: A Dosimetric MethodThyroid®, 2001
- Successful Treatment of a Patient with Graves' Disease on Hemodialysis Complicated by Antithyroid Drug-Induced Granulocytopenia and Angina PectorisThyroid®, 1997
- Radioiodine Treatment of Thyroid Carcinoma in Patients on Maintenance HemodialysisThyroid®, 1996
- Management of Thyroid Papillary Carcinoma With Radioiodine in a Patient With End Stage Renal Disease on HemodialysisClinical Nuclear Medicine, 1994
- 131I treatment of thyroid papillary carcinoma in a patient with renal failureCancer, 1990
- Iodine 131 ablation therapy for a patient on maintenance haemodialysisBritish Journal of Radiology, 1981
- Clinical hyperthyroidism in a patient receiving long-term hemodialysisArchives of internal medicine (1960), 1980